Souzan Sanati

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

Matthew J. Ellis, Vera J. Suman, Jeremy Hoog et al. · Journal of Clinical Oncology · 2017 · 411 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor–Positive Breast Cancer

X. Cynthia, Feng Gao, Jingqin Luo et al. · Clinical Cancer Research · 2017 · 376 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Kuan‐lin Huang, Shunqiang Li, Philipp Mertins et al. · Nature Communications · 2017 · 155 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Improved laboratory resource utilization and patient care with the use of rapid on‐site evaluation for endobronchial ultrasound fine‐needle aspiration biopsy

Brian T. Collins, Alexander C. Chen, Jeff F. Wang et al. · Cancer Cytopathology · 2013 · 84 citations · Full text

Veterinary Medicine, Clinical Sciences, Pulmonology +13

A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i> -Mutant ER-Positive and HER2-Negative Breast Cancer

X. Cynthia, Vera J. Suman, Matthew P. Goetz et al. · Clinical Cancer Research · 2017 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17